Introduction
Glomerular diseases are a leading cause of chronic and endstage kidney failure worldwide, and an array of glomerular diseases is distinguished by glomerular mesangial cell (GMC) injury, including membranoproliferative glomerulonephritis, IgA nephropathy, and diabetic nephropathy. In a pathophysiological state, GMCs typically lead to expansion of the mesangial matrix and they undergo cell proliferation and hypertrophy and apoptosis. The phenomena are closely correlated with deterioration of renal function, so GMCs have long been considered an important factor in progressive renal failure (1) .
Integrin-linked kinase (ILK) is known to be a widely expressed serine/threonine protein kinase localized to focal adhesion plaques and centrosomes (2, 3) . ILK plays a fundamental role in the regulation of cell survival, proliferation, and migration by connecting the cytoplasmic domains of β-integrins to the actin cytoskeleton, mediating integrin signaling in diverse cell types (3) . An increase in the ILK level in the mesangium is associated with diffuse mesangial expansion. ILK is a downstream mediator of int egrin β1 activity, and integrin/ILK signal pathways are involved in the regulation of cell adhesion, changes in cell morphology, and extracellular matrix (ECM) deposition (4) . Overexpression of ILK can result in ECM remodeling and cell proliferation by GMCs (5) .
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor family consisting of three subtypes (α, δ, and γ) with distinct and overlapping expression patterns (6) . These lipid-
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Fish oil containing n-3 polyunsaturated fatty acids (n- Original Article sensitive receptors regulate many important physiological processes including glucose and lipid metabolism, energy homeostasis, cell proliferation, inflammation, immunity and reproduction (7) . PPARγ is expressed in several types of tissue, including kidney tissue. In addition to regulating glucose and lipid metabolism, PPARγ has antiinfl ammatory and anti-fi brotic action in kidney diseases (8) .
Eicosapentaenoic acid (EPA, C20:5 n-3) and docosahexaenoic acid (DHA, C22:6 n-3), which belong to the n-3 polyunsaturated fatty acid (PUFA) family, are the main components of fi sh oil from deep sea fi sh. Fish oil, a type of PPARγ natural ligand, has been reported to slow the progress of kidney disease. A diet rich in n-3 PUFA, like EPA and DHA, has been associated with reduced triacylglycerol (TAG) levels, anti-infl ammatory action, pulmonary disease (9) , and a lowered risk of cardiovascular disease and mortality (10) (11) (12) (13) . A higher dietary intake of PUFA may protect against progression of chronic kidney disease (14) . Clinical trials have provided conflicting results with regard to the efficacy of n-3 PUFA in treating IgA nephropathy, although in vitro and in vivo experimental studies have indicated that n-3 PUFA act on infl ammatory pathways involved in the progression of kidney disease (15) .
Despite increasing knowledge of the benefi cial effects of fish oil in treating nephropathy, the exact mechanisms underlying its renoprotective effects are not fully understood. Previous studies by the current authors showed that EPA and DHA inhibited the proliferation of GMCs induced by lipopolysaccharide (LPS) (16) . Furthermore, the protective effects of EPA and DHA on the kidney were found to be related to their action to suppress TGF-β1 and MCP-1 expression in GMCs (17) . In addition, EPA and DHA may protect GMCs by regulating the imbalance of MMP and TIMP expression (18) . The present study sought to examine the effects of EPA and DHA on the expression of PPARγ, ILK, and integrin β1 in rat GMSs in order to further investigate the renoprotective action of fi sh oil.
Materials and Methods

Chemicals and antibodies
EPA, DHA, and LPS were purchased from Sigma-Aldrich (St. Louis, MO, USA). RPMI 1640 and fetal bovine serum (FBS) were purchased from Life Technologies (Carlsbad, CA, USA). Rabbit anti-rat ILK and rabbit anti-rat PPARγ were from Santa Cruz Biotechnology (Dallas, TX, USA). Monoclonal antibody against β-actin was purchased from Beijing Jing Mei Biotechnology (Beijing, China). All primers were synthesized by BioSune (Shanghai, China). Green real-time PCR master mix was purchased from Toyobo Biotech (Shanghai, China).
Cell culture
Rat GMCs (HBZY-1) were purchased from the Chinese Center for Typical Culture Collection (Wuhan, Hubei, China). GMCs were routinely cultured in RPMI-1640 media supplemented with 10% FBS. For experiments, GMCs were divided into six groups: i) Control group: cells were cultured in RPMI-1640 during the entire study; ii) LPS group: cells were treated with 10 μg/mL LPS; iii) Low-dose EPA group: cells were treated with 10 μg/mL LPS and 10 μmol/L EPA; iv) High-dose EPA group: cells were treated with 10 μg/mL LPS and 100 μmol/L EPA; v) Low-dose DHA group: cells were treated with 10 μg/mL LPS and 10 μmol/L DHA; vi) High-dose DHA group: cells were treated with 10 μg/mL LPS and 100 μmol/L DHA. Each experiment was repeated three times.
RNA isolation and quantitative real-time polymerase chain reaction (PCR)
After incubation for 24 h or 48 h, GMCs were harvested and total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Complement DNA (cDNA) was synthesized using a Super Script III first strand cDNA synthesis Kit (Invitrogen). Real-time PCR was performed with SYBR Green PCR Master Mix kits (Applied Biosystems, Foster City, CA, USA) and an ABI Prism 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA). Gene-specifi c primer sequences are listed in Table 1. β-Actin was used as an internal control to quantify mRNA expression. The relative expression of the target gene = intensity of fl uorescence of target gene fragments/ intensity of fluorescence of the β-actin gene. Cycling conditions were 94ºC, 3 min, followed by 40 cycles of 94ºC, 30 sec; 60ºC, 30 sec; and 72ºC, 1 min.
Western blotting
After incubation for 24 h or 48 h, cells were harvested and lysed. The protein concentration was determined using the Coomassie Brilliant Blue method. Equal amounts of lysate proteins from whole-cell lysates were loaded onto (Figure 2A ) and 48 h ( Figure 2B ) resulted in a signifi cant increase in PPARγ mRNA expression in comparison to that in the LPS group (p < 0.05 or p < 0.01).
EPA and DHA reduced ILK expression in GMCs
The rise in the ILK level in the mesangium is associated with diffuse mesangial expansion. Whether EPA or DHA is able to diminish ILK expression in GMCs was ascertained at the mRNA level and at the protein level.
ILK protein expressed by GMCs was evaluated using Western blotting. Exposure of cultured GMCs to 10 μg/mL LPS induced a significant increase in ILK expression in comparison to that in the control group (p < 0.01 at 24 and 48 h, Figure 3 ). Incubation of GMCs treated with EPA 10% gels and separated using SDS-PAGE. Then gels were transferred to a polyvinylidene difl uoride membrane. After blocking for 2 h at room temperature in blocking buffer, the membrane was incubated overnight with rabbit anti-rat PPARγ or rabbit anti-rat ILK. Blots were washed and then incubated with a secondary goat antibody raised against rabbit IgG conjugated to horseradish peroxidase. After further washing, the bound antibodies were visualized using an ECL kit, and band densities were measured using TINA imaging software (Raytest, Straubenhardt, Germany). The level of β-actin protein served as a protein loading control.
Statistical analysis
Data are expressed as mean ± SD. One-way ANOVA followed by Dunnett's test was performed using SPSS/ Win11.0 software (SPSS, Inc., Chicago, IL, USA). A signifi cant difference was defi ned as p < 0.05.
Results
EPA and DHA increased PPARγ expression in GMCs
The effects of EPA and DHA on PPARγ expression were examined at the mRNA level and at the protein level in GMCs treated with LPS.
PPARγ protein expressed by GMCs was evaluated using Western blotting. Exposure of cultured GMCs to 10 μg/mL LPS induced a significant decrease in PPARγ expression in comparison to that in the control group (p < 0.01 at 24 h and 48 h, Figure 1 ). Incubation GMCs cultured with 10 μg/mL LPS and treated with EPA (100 μmol/L) or DHA (100 μmol/L) for 24 h resulted in a significant increase in PPARγ protein expression (p < 0.01, vs. LPS group, Figure 1A ). In addition, incubation of GMCs treated with 100 μmol/L of EPA or 10 μmol/L or 100 μmol/L of DHA for 48 h markedly increased the expression of PPARγ (p < 0.05 or p < 0.01, vs. LPS group, Figure 1B) . Levels of PPARγ mRNA in GMCs were determined using real-time PCR. As shown in Figure 2 , the ratio of the (10 μmol/L and 100 μmol/L) or DHA (10 μmol/L and 100 μmol/L) for 24 h had no significant effect on ILK protein expression (p ˃ 0.05, vs. LPS group, Figure 3A) . However, incubation of GMCs treated with 10 μmol/L or 100 μmol/L of EPA or 10 μmol/L or 100 μmol/L of DHA for 48 h significantly decreased the expression of ILK protein (p < 0.01, Figure 3B) .
Levels of ILK mRNA in GMCs were determined using real-time PCR. As shown in Figure 4 , the levels of ILK mRNA dramatically increased in the LPS group (p < 0.01 at 24 h and 48 h). Incubation of GMCs treated with EPA (10 μmol/L and 100 μmol/L) or DHA (10 μmol/L and 100 μmol/L) for 24 h resulted in a signifi cant decrease in ILK mRNA expression in comparison to that in the LPS group (p < 0.01, Figure 4A ). Incubation of GMCs treated with 100 μmol/L of EPA or 10 μmol/L or 100 μmol/L of DHA for 48 h signifi cantly decreased the expression of ILK mRNA (p < 0.05 or p < 0.01 vs. LPS group, Figure 4B ).
EPA and DHA reduced integrin β1 expression in GMCs
ILK is a downstream mediator of integrin β1 activity, and integrin/ILK signal pathways are involved in the regulation of cell adhesion, changes in cell morphology, and ECM deposition. Whether EPA or DHA was able to diminish integrin β1 mRNA expression in GMCs was ascertained.
Levels of integrin β1 mRNA in GMCs were determined using real-time PCR. As shown in Figure 5 , the levels of integrin β1 mRNA dramatically increased in LPStreated cells (p < 0.01 at 24 h and 48 h, vs. control group). Incubation of GMCs treated with EPA (100 μmol/L) for 24 h resulted in a significant decrease in integrin β1 mRNA expression in comparison to that in the LPS group (p < 0.05; Figure 5A ). Incubation of GMCs treated with 10 μmol/L or 100 μmol/L of EPA or 10 μmol/L or 100 μmol/L of DHA for 48 h signifi cantly decreased the expression of integrin β1 mRNA in comparison to that in the LPS group (p < 0.05 or p < 0.01, Figure 5B ).
Discussion
This study investigated the mechanisms underlying the renoprotective effect of EPA and DHA in GMCs in vitro. Results indicated that EPA and DHA signifi cantly increased the expression of PPARγ and reduced the expression of ILK and i ntegrin β1 in GMCs, and these levels of expression changed dramatically when cells were cultured with LPS. These results suggest that the renoprotective effects of EPA and DHA are possibly related to their effects on the expression of PPARγ, ILK, and integrin β1 in GMCs.
PPARγ plays an important role in mesangial cells responding to inflammatory stress. PPARγ protein expression increased dramatically in human mesangial cells stimulated with interleukin-1β (IL-1β), and the levels of interleukin-6 (IL-6) and tumor necrosis factor α (TNFα) increased signifi cantly in comparison to those in untreated cells (19) . A key finding is that PPARγ agonists, including troglitazone, rosiglitazone, and prostaglandin J2, significantly decrease the increased expression of TNFα and IL-6 (19) . Rosiglitazone inhibits mesangial cell proliferation by blocking reactive oxygen species (ROS)-dependent epidermal growth factor receptor (EGFR) intracellular signaling, and telmisartan has powerful anti-infl ammatory action via PPARγ activation in mesangial cells (20) . PPARγ may prove to be a pharmacological target for treatment of glomerulonephritis (19) . Fish oil reduced an LPSinduced inflammatory response in HK-2 cells via a PPARγ dependent pathway (21) . The current results indicated that both EPA and DHA effectively upregulated PPARγ mRNA and protein expression. Thus, fish oil may play a role by activating PPARγ. PPARγ agonists are effective in delaying and even preventing the progression of many renal diseases (7) . These data suggest that PPARγ plays an important role in the response of mesangial cells to inflammatory stress. PPARγ may represent a potential target for the treatment of renal diseases (7) .
ILK is a focal adhesion adaptor and a serine/threonine protein kinase that regulates cell proliferation, survival, epithelial-mesenchymal transition (EMT), and kidney development (22, 23) . It acts as a central component of a heterotrimer (the PINCH-ILK-parvin complex) at ECM adhesions, mediating interactions with a large number of proteins via multiple sites including its p seudoactive site. ILK links integrins to the actin cytoskeleton and catalytic proteins and thereby regulates focal adhesion assembly, cytoskeleton organization, and signaling (24) . Increased activity of ILK and integrin β1 in GMCs may contribute to the development of sustained mesangial cell proliferation and lead to glomerular scarring (5) . In aging kidneys, integrin β1 and ILK may be involved in the process of fibrosis and related senescence (25) . ILK also plays an important role in the pathogenesis of nephropathy in GMCs and also in podocytes of the kidney (26, 27) . In the present study, EPA and DHA decreased the expression of ILK and integrin β1 in GMCs stimulated with LPS. This finding confirms the assertion that ILK and integrin β1 play a role in lipidinduced kidney injury.
Interestingly, there may be a relationship between PPARγ and ILK. A study found that f ish oil inhibited the proliferation of non-small cell lung carcinoma by suppressing ILK expression via activation of PPARγ (28) .
In summary, the present study suggests that EPA and DHA are capable of increasing PPARγ expression and decreasing ILK and integrin β1 expression in GMCs treated with LPS. This study provides novel insights into the mechanisms of the renoprotective effects of fi sh oil.
